Molecular mechanism of calcium channel block by isradipine - Role of a drug-induced inactivated channel conformation

被引:35
作者
Berjukow, S [1 ]
Marksteiner, R [1 ]
Gapp, F [1 ]
Sinnegger, MJ [1 ]
Hering, S [1 ]
机构
[1] Inst Biochem Pharmakol, A-6020 Innsbruck, Austria
关键词
D O I
10.1074/jbc.M908836199
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The role of the inactivated channel conformation in the molecular mechanism of Ca2+ channel block by the 1,4-dihydropyridine (DHP) (+)-isradipine was analyzed in L-type channel constructs (alpha(1LC); Berjukow, S., Gapp, F., Aczel, S., Sinnegger, M. J., Mitterdorfer, J., Glossmann, H., and Hering, S. (1999) J. Biol. Chem. 274, 6154-6160) and a DHP-sensitive class A Ca2+ channel mutant (alpha(1A-DHP); Sinnegger, M. J,, Wang, Z,, Grabner, RI., Hering, S., Striessnig, J., Glossmann, H., and Mitterdorfer, J. (1997) J. Biol Chem. 272, 27686-27693) carrying the high affinity determinants of the DHP receptor site but inactivating at different rates. Ca2+ channel inactivation was modulated by coexpressing the alpha(1A-DHP)- or alpha(1LC)-subunits in Xenopus oocytes with either the beta(2a)- or the beta(1a)-subunit and amino acid substitutions in L-type segment IVS6 (I1497A, I1498A, and V1504A). Contrary to a modulated receptor mechanism assuming high affinity DHP binding to the inactivated state we observed no clear correlation between steady state inactivation and Ca2+ channel block by (+)-isradipine: (i) a 3-fold larger fraction of alpha(1A-DHP/beta 1a), channels in steady state inactivation at -80 mV (compared with alpha(1A-DHP)/beta(2a)) did not enhance the block by (+)-isradipine; (ii) different steady state inactivation of alpha(1Lc) mutants at -30 mV did not correlate with voltage-dependent channel block; and (iii) the midpoint-voltages of the inactivation curves of slowly inactivating L-type constructs and more rapidly inactivating alpha(1Lc)/beta(1a) channels were shifted to a comparable extent to more hyperpolarized voltages. A kinetic analysis of (+)-isradipine interaction with different L-type channel constructs revealed a drug-induced inactivated state. Entry and recovery from drug-induced inactivation are modulated by intrinsic inactivation determinants, suggesting a synergism between intrinsic inactivation and DHP block.
引用
收藏
页码:22114 / 22120
页数:7
相关论文
共 26 条
[1]   NITRENDIPINE BLOCK OF CARDIAC CALCIUM CHANNELS - HIGH-AFFINITY BINDING TO THE INACTIVATED STATE [J].
BEAN, BP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (20) :6388-6392
[2]   Sequence differences between α1C and α1S Ca2+ channel subunits reveal structural determinants of a guarded and modulated benzothiazepine receptor [J].
Berjukow, S ;
Gapp, F ;
Aczél, S ;
Sinnegger, J ;
Mitterdorfer, J ;
Glossmann, H ;
Hering, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) :6154-6160
[3]   Molecular studies on the voltage dependence of dihydropyridine action on L-type Ca2+ channels - Critical involvement of tyrosine residues in motif IIIS6 and IVS6 [J].
Bodi, I ;
Yamaguchi, H ;
Hara, M ;
He, M ;
Schwartz, A ;
Varadi, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (40) :24952-24960
[4]   MOLECULAR-PROPERTIES OF A SUPERFAMILY OF PLASMA-MEMBRANE CATION CHANNELS [J].
CATTERALL, WA .
CURRENT OPINION IN CELL BIOLOGY, 1994, 6 (04) :607-615
[5]   Voltage and calcium use the same molecular determinants to inactivate calcium channels [J].
Cens, T ;
Restituito, S ;
Galas, S ;
Charnet, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (09) :5483-5490
[6]   Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels [J].
Grabner, M ;
Wang, ZY ;
Hering, S ;
Striessnig, J ;
Glossmann, H .
NEURON, 1996, 16 (01) :207-218
[7]   Ca2+ channel block and inactivation:: common molecular determinants [J].
Hering, S ;
Berjukow, S ;
Aczél, S ;
Timin, EN .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (11) :439-443
[9]  
Hille B., 1978, BIOPHYSICAL ASPECTS, P55
[10]   Molecular determinants of drug binding and action on L-type calcium channels [J].
Hockerman, GH ;
Peterson, BZ ;
Johnson, BD ;
Catterall, WA .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :361-396